piperazine has been researched along with pbtz169 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, L; Gu, J; Guo, H; Liu, M; Lu, Y; Lv, K; Ma, C; Tao, Z; Wang, A; Wang, B; Wang, H | 1 |
| Chen, X; Fu, L; Guo, S; Liu, M; Lu, Y; Wang, B; Zhao, J | 1 |
2 other study(ies) available for piperazine and pbtz169
| Article | Year |
|---|---|
Synthesis and antitubercular evaluation of reduced lipophilic imidazo[1,2-a]pyridine-3-carboxamide derivatives.
Topics: Antitubercular Agents; Area Under Curve; Drug Resistance, Multiple; Hydrophobic and Hydrophilic Interactions; Imidazoles; Mycobacterium tuberculosis; Piperazine; Piperazines; Pyridines; Structure-Activity Relationship; Thiazines | 2019 |
In vitro and in vivo antimicrobial activities of a novel piperazine-containing benzothiazinones candidate TZY-5-84 against Mycobacterium tuberculosis.
Topics: Animals; Antitubercular Agents; Dose-Response Relationship, Drug; Female; Macrophages; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Piperazine; Piperazines; Thiazines; Time Factors; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2020 |